المؤلفون: Castellano, D. E., Bodrogi, I., Booth, J. L., Rosamilia, M., Yuan, R. R., Hawkins, R., Knox, J. J., Blank, C. U., Gruenwald, V., Karakiewicz, P. I., Bavbek, S. E., Miller, K., Machiels, J. H., Lee, S., Larkin, J. M. G., Bono, P., Rha, S. Y.

المساهمون: 200541

مصطلحات موضوعية: Tıp, Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları, Onkoloji, Klinik Tıp (MED), ONKOLOJİ, Klinik Tıp

Relation: JOURNAL OF CLINICAL ONCOLOGY; Gruenwald V., Karakiewicz P. I. , Bavbek S. E. , Miller K., Machiels J. H. , Lee S., Larkin J. M. G. , Bono P., Rha S. Y. , Castellano D. E. , et al., "Final results of the international, expanded-access program of everolimus in patients with advanced renal cell carcinoma who progress after prior vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy.", JOURNAL OF CLINICAL ONCOLOGY, cilt.29, 2011; av_9d799c20-19b8-4a8a-bcbc-e2710e55158c; vv_1032021; http://hdl.handle.net/20.500.12627/105800; 29; 15

الاتاحة: https://hdl.handle.net/20.500.12627/105800

المؤلفون: Yuan, R R, Spira, G, Oh, J, Paizi, M, Casadevall, A, Scharff, M D

المصدر: Infection and Immunity; March 1998, Vol. 66 Issue: 3 p1057-62, 6p